TAT-CBD3A6K
TAT-CBD3A6K is a modified TAT-CBD3 peptide. It reduces T-type and R-type voltage-dependent calcium currents in dorsal root ganglion (DRG) neurons. By inhibiting CRMP-2-mediated enhancement of T-type and R-type calcium channel function, TAT-CBD3A6K exhibits anti-nociceptive effects in models of AIDS-induced peripheral neuropathy.
Product Specifications
Field of Research
Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Molecular Weight
3249.83
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog